Lexington County-based Nephron Pharmaceuticals is being sued by another drug manufacturer, which claims Nephron products are being marketed as a replacement for its own drug without FDA approval.

Lou Kennedy, CEO of Nephron Pharmaceuticals takes Sen. Lindsey Graham on a 2020 tour of the facility in Cayce. 5/15/20 Tracy Glantz [email protected] Nephron Pharmaceuticals has furloughed at least ...

Three years ago, the FDA found so many violations at a Nephron Pharmaceuticals manufacturing facility that the U.S. regulator admitted in a warning letter the issues were so numerous they couldn’t all ...

The medical-grade glove manufacturing plant that was an expansion of Nephron, one of the largest companies in the Midlands, owes Lexington County nearly $1 million in overdue property taxes despite ...

A recent inspection at a South Carolina drug production facility flagged several problems with how the company was producing drugs for the mass market, little more than a year after the same facility ...

Nephron Research upgraded Medtronic (MDT) to Buy from Hold with a $120 price target The firm says the company’s pickup in growth “has legs.” ...

Nephron number varies widely in healthy adults. The extent to which this variation is due to differences in nephron endowment at birth and/or nephron loss with ageing is unclear. A recent study used a ...

WEST COLUMBIA, S.C. (WIS) - The FDA filed a letter warning a West Columbia pharmaceutical company to correct violations or it may face seizure or injunction. Nephron Pharmaceutical has been under ...

“You’re on a chemotherapeutic and your oncologist may say that your dosage is X, while a nephrologist is telling you that the proximal tubules in your kidneys can’t handle it. You’re harming them.” ...